In the wake of the novel coronavirus outbreak , the biopharmaceutical company with the highest market capitalization change of over nine billion dollars - in the given time range - was Gilead Sciences as they started phase three trials of their antiviral drug remdesivir for the treatment of COVID-19 . This statistic depicts the market capitalization changes of select biopharmaceutical companies which are involved in R & D on the novel coronavirus to find treatments or vaccines , in regards to the period from January 20 to February 25 , 2020 .
